Results 181 to 190 of about 229,057 (243)

Prolonged versus single dose in penicillin oral challenge testing: protocols for a pilot and definitive randomised controlled trial (PROSPECTOR studies). [PDF]

open access: yesBMJ Open
Ng I   +15 more
europepmc   +1 more source

Food oral immunotherapy. [PDF]

open access: yesAllergy Asthma Clin Immunol
McHenry M   +4 more
europepmc   +1 more source

The National Academies’ 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology Community

open access: yes
Arthritis &Rheumatology, EarlyView.
Leonard H. Calabrese   +6 more
wiley   +1 more source

Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Computed Tomography

open access: yesArthritis &Rheumatology, EarlyView.
Objective This study aimed to ascertain the effect of secukinumab on erosion and enthesiophyte progression in psoriatic arthritis (PsA) by using high‐resolution peripheral quantitative computed tomography (HR‐pQCT). Methods This was a phase 4, double‐blind, randomized, placebo‐controlled trial.
Yingzhao Jin   +11 more
wiley   +1 more source

Moisturizer induced contact anaphylaxis. [PDF]

open access: yesAllergy Asthma Clin Immunol
Jeffrey B   +4 more
europepmc   +1 more source

Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA)–associated anticitrullinated protein antibodies (ACPAs) target various antigens by binding short citrulline amino acid motifs, resulting in heterogeneous ACPA profiles among patients. Here we analyzed ACPA patterns by recognized citrulline motifs in relation to the RA risk factors HLA‐DRB1 shared epitope (SE) alleles
Linda Mathsson Alm   +18 more
wiley   +1 more source

Introduction from the editors. [PDF]

open access: yesAllergy Asthma Clin Immunol
Kim H, Ellis AK, Watson W.
europepmc   +1 more source

Home - About - Disclaimer - Privacy